Filing Flows › Mesa Laboratories (MLAB) › Q1 FY27 › vs Q1 FY26
Mesa Laboratories (MLAB) Q1 FY27 vs Q1 FY26 (year over year)
Mesa Laboratories's revenue rose $595K (+1%) from $59.5M in Q1 FY26 to $60.1M in Q1 FY27. Gross margin 64.9% against 62.0% (+2.8 pts).
Mesa Laboratories, Q1 FY27: revenue $60.1M (+1% year over year), operating margin 11.7%, net earnings $2.8M, operating cash flow $14.7M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Gross margin | 64.9% | 62.0% | +2.8 pts |
| Operating margin | 11.7% | 5.1% | +6.5 pts |
| Net margin | 4.7% | 8.0% | -3.3 pts |
| Free cash flow margin | 23.6% | 1.5% | +22.1 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $60.1M | $59.5M | $595K | +1% |
| Gross profit | $39.0M | $36.9M | $2.1M | +6% |
| Cost of revenue | $21.1M | $22.6M | −$1.5M | -7% |
| Operating profit | $7.0M | $3.1M | $4.0M | +129% |
| Operating expenses | $32.0M | $33.9M | −$1.9M | -6% |
| Pre-tax earnings | $4.4M | $7.0M | −$2.7M | -38% |
| Other expense, net | $2.7M | −$3.9M | $6.6M | — |
| Research & development | $4.7M | $5.0M | −$259K | -5% |
| Sales & marketing | $9.9M | $10.9M | −$1.1M | -10% |
| General & admin | $17.4M | $18.0M | −$574K | -3% |
| Net earnings | $2.8M | $4.7M | −$1.9M | -40% |
| Income tax | $1.5M | $2.3M | −$747K | -33% |
| Depreciation & amortization | $5.6M | $6.0M | −$312K | -5% |
| Share-based compensation | $2.4M | $3.9M | −$1.5M | -39% |
| Working capital & other | $3.9M | −$12.7M | $16.6M | — |
| Operating cash flow | $14.7M | $1.9M | $12.8M | +678% |
| Free cash flow (OCF − capex) | $14.2M | $884K | $13.3M | 16× |
| Capital expenditures | $559K | $1.0M | −$450K | -45% |
Questions
How much did Mesa Laboratories's revenue grow year over year in Q1 FY27?
Mesa Laboratories's revenue rose $595K (+1%) from $59.5M in Q1 FY26 to $60.1M in Q1 FY27. Gross margin 64.9% against 62.0% (+2.8 pts).